Ghana turns to the Czech Republic to structure its cannabis industry

Ghana has made official contact with Czech Republic for a commercial mission scheduled for April 2026 in Prague, headed by Chamber of the Cannabis Industry of Ghana (Cannacham).

This project follows recent meetings between Cannacham and representatives of the Czech Embassy in Accra, aimed at establishing cooperation along the entire cannabis value chain.

Discussions focused on medical cannabis, industrial hemp, research, technology transfer, capacity building and foreign direct investment, with Ghana's ambition to move beyond simple cultivation towards higher value-added activities.

A European gateway to Ghana's ambitions

According to the Dr Mark Darko, Cannacham's Managing Director, the Czech Republic offers a combination of regulatory maturity and technical expertise that closely matches Ghana's long-term objectives.

«This trade mission to the Czech Republic is not an international trade mission,» said Dr. Darko, pointing out that despite its national setting, the event should attract stakeholders from around the world.’Europe and North America, companies, in particular Canada, the United States, Germany and the Netherlands.

The Czech Republic has been running a medical cannabis program since 2013. allows cannabis self-cultivation from January 2026. It has also introduced innovative frameworks such as the law on mood-altering substances, which regulates products with low THC content, positioning the country as an exception in terms of regulation within the’European Union.

From a market perspective, the Czech cannabis sector was valued at 41 million in 2024, according to estimates by Prohibition Partners, and should see average annual growth of over 5% until 2028.

Technology, research and value-added processing

For Ghana, the appeal goes beyond market size. The Czech Republic's strengths in terms of agricultural technology, d’precision agriculture, pharmaceutical research and quality standards are considered essential to Ghana's ambition to develop a value-added processing rather than simply being a supplier of raw materials.

Dr. Darko has repeatedly stressed that Ghana's goal is to anchor itself in established international supply chains rather than develop its industry in isolation. The April mission aims to connect Ghanaian producers and regulators directly with technology providers, investors and compliance specialists familiar with EU regulatory requirements.

This initiative also reflects Ghana's realization that competitiveness in global cannabis markets depends on more than just favorable climatic conditions. Genetic control, laboratory analysis capabilities, traceability systems and good manufacturing practices are now basic requirements for export-oriented operations.

The climate advantage in the face of regulatory uncertainty

Ghana's tropical climate remains one of its key advantages. Cannabis can be grown all year round, unlike many European and North American markets where production relies heavily on energy-intensive indoor facilities.

This cost advantage has attracted growing interest from international contractors. However, investment has been held back by persistent uncertainty regarding licensing rights, operational requirements and export procedures. While Ghana has legalized cannabis medical and industrial purposes thanks to amendments to the Narcotics Control Board Act, secondary regulations governing day-to-day operations continue to evolve.

Cannacham has also explored partnerships with Israel, by focusing on irrigation, genetics and precision farming, or with Morocco to study options for regulating cannabis.